How to Read SART Data: Understanding Clinic Success Rates

Evidence-based clinical guidance · Updated 2026
Quick Answer

The most reliable SART metric is live births per intended egg retrieval — not per transfer, which inflates success numbers by excluding failed cycles. Clinics can game their rates through patient selection, multi-embryo transfers, and selective emphasis. Compare clinics within your age group, check sample sizes, and ask about metrics SART doesn't report (blastocyst conversion, freeze/thaw survival).

Key Takeaways

1

Live births per intended egg retrieval is the only metric that doesn't exclude patients who failed before transfer — always use this for comparisons

2

Per-transfer rates inflate success by excluding cancelled cycles, failed fertilization, and patients with no transferable embryos

3

Clinics with unusually high success rates may be turning away difficult cases or using multi-embryo transfers — investigate before assuming they're 'better'

4

SART data doesn't capture patient experience, lab quality specifics, pricing, or your individual prognosis — it's one input, not the whole picture

Why Clinic Success Rates Are Confusing (By Design)

SART (Society for Assisted Reproductive Technology) publishes IVF success rate data for member clinics — and most patients look at these numbers at some point. The problem: the data is genuinely useful but easy to misinterpret, and some clinics exploit this ambiguity in their marketing.

This guide will teach you to read SART data like a clinician, not a patient being marketed to.

The Most Important Number: Live Births Per Intended Egg Retrieval

SART reports multiple outcome metrics. Here's what each means and why one matters most:

MetricWhat It MeasuresManipulation RiskUsefulness
Live births per intended egg retrievalPercentage of patients who start a retrieval cycle and end up with a babyLow — hardest to gameHIGHEST — this is your best apples-to-apples metric
Live births per transferPercentage of embryo transfers resulting in a live birthHIGH — excludes patients who never made it to transferMisleading — inflated by excluding failed cycles
Clinical pregnancy rate per transferPercentage of transfers resulting in a detectable pregnancyHIGH — includes pregnancies that don't reach viabilityLow — pregnancies ≠ babies
Live births per patient (cumulative)Total live births across all cycles for patients who started treatmentModerate — depends on how many cycles patients doUseful for long-term planning, less so for per-cycle decisions

💡 Always look at live births per intended egg retrieval. A clinic boasting '60% pregnancy rate per transfer' may sound amazing, but if only 50% of patients make it to transfer, the effective rate per retrieval attempt is much lower.

How Clinics Game Their Numbers

This isn't about fraud — it's about selective emphasis and patient selection practices that make numbers look better than they are:

Patient Selection

Reporting Practices

📊 What the Research Shows

A 2023 analysis in Fertility and Sterility found that when adjusted for patient mix, age, and transfer practices, the actual performance gap between most SART clinics was smaller than published rates suggested. Patient selection and reporting emphasis accounted for a substantial portion of apparent clinic differences.

How to Read SART Data: Step by Step

Go to sart.org/patients/a-patients-guide-to-assisted-reproductive-technology/ and:

  1. Select your age group — data is broken down by <35, 35–37, 38–40, 41–42, >42
  2. Look at "live births per intended egg retrieval" — this is your primary comparison metric
  3. Check number of cycles reported — small sample sizes (<50 cycles in your age group) make statistics unreliable. Prefer clinics with larger volumes for more meaningful data.
  4. Compare single vs. multi-embryo transfer rates — high SET rates with good outcomes indicate better lab quality and clinical confidence
  5. Look at the cancellation rate — very low cancellation might mean the clinic starts cycles it shouldn't; very high might mean data management
  6. Check the freeze-all rate — high freeze-all rates are normal in modern practice; they don't indicate a problem

What SART Data Can't Tell You

National IVF Averages for Context (2024 SART Data)

Age GroupLive Birth Per Retrieval (own eggs)Avg Eggs RetrievedSingle Embryo Transfer Rate
<3545–55%12–1885–95%
35–3735–42%8–1480–90%
38–4022–30%6–1170–85%
41–4210–18%4–860–75%
>423–10%2–550–65%

📊 Clinics reporting significantly above these averages deserve scrutiny — check their patient selection practices and transfer policies. Clinics significantly below may have valid explanations (taking harder cases, new lab, transition period) or may have quality issues worth investigating.

For red flags when evaluating clinics beyond the data, see Fertility Clinic Red Flags. For the emotional side of clinic shopping, FertileStart has validation-first resources.

Frequently Asked Questions

Visit sart.org and navigate to 'Find a Clinic' or the patient guide section. You can search by location and compare clinics by age group and outcome metric.

National averages for live birth per retrieval: 45–55% for under 35, 35–42% for 35–37, 22–30% for 38–40, 10–18% for 41–42. Clinics within or above these ranges are performing well.

Often: patient selection (turning away difficult cases), multi-embryo transfer practices, or emphasis on per-transfer rather than per-retrieval metrics. Always check the context behind impressive-looking numbers.

Not necessarily. Consider patient experience, location, cost, communication quality, and whether the clinic treats patients like yours. A slightly lower success rate at a clinic with excellent communication and individualized care may be better overall.

At least 50 cycles in your age group for statistically meaningful data. Fewer than 20–30 cycles means success rates could swing widely based on a few outcomes.

Continue Your Research

LifeFertile
Supplements & lifestyle optimization
FertileStart
TTC basics & emotional support
HowToHaveABaby
Complete fertility hub & guides
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified reproductive endocrinologist or healthcare provider for personalized guidance. Clinical data referenced is current as of publication but may evolve as new research emerges.